Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

The Value of the Biotech Companies Continued

September 23, 2019 0

Prohost Letter #435 The Value of the Biotech Companies A Continuation of Prohost Letter #434 A …

At bluebird bio an Investigational Gene Therapy is Demonstrating Promising Results

September 20, 2019 0

bluebird bio Has Promising Results from Its Lenti-D Gene Therapy for CALD Good results have come …

Atara Allogeneic Product ATA188 Will Confirm Whether EBV Infecting B Cells Could Cause a Difficult to Treat Kind of MS

September 17, 2019 0

Atara Biotherapeutics ATA188 for MS Atara Biotherapeutics (ATRA) announced the presentation of initial efficacy data as …

Why Alder Biopharmaceuticals Stock Gained Over 83%. See Also: Prohost Picked Stocks Outperforming in a Down Market Day

September 16, 2019 0

Migraine's Really Effective Treatments The years 2018 and 2019 could be called the years of migraine’s …

Moderna Therapeutics: A Big Day Filled with Good News

September 13, 2019 0

Moderna Therapeutics Trial Results Moderna Therapeutics (MRNA) trial results mark the first systemic mRNA therapeutic to …

About RegenxBio’s Agreement with Clearside Biomedical and More

September 10, 2019 0

Diseases of the Back of the Eye Diseases of the back of the eye, such as: age-related …

Amgen’s Oncology Product AMG-510 Meeting An Unmet Need for Kras G12C Mutated Cancers

September 9, 2019 0

Amgen's Outperforming After being boxed in, for the past couple of weeks, Amgen’s (AMGN) stock finally outperformed. …

Vertex: In Pursuit of Cures

September 4, 2019 0

Vertex Pharmaceuticals Is Acquiring Semma Therapeutics Vertex Pharmaceutical (VRTX) entered into a definitive agreement to buy a …

Outperforming Biotechs In a Bad Market Day

September 3, 2019 0

Outperforming Biotechs On August 27, 2019 we posted “The Medicines Company Has Agreeable News” under Today’s …

Gene Therapy and Other Treatments That Work at the Genetic Level

August 30, 2019 0

Gene Therapy Stocks Experiencing Selloffs Every investor in the biotech sector must have experienced selloffs of …

The Medicines Company Has Agreeable News

August 27, 2019 0

The Medicines Company The Medicines Company (MDCO) focuses on cardiovascular diseases. Major goals are halting the …

Amgen to Acquire Celgene’s Product Otezla at $13.4 Billion

August 26, 2019 0

Amgen Agreement with Celgene for Otezla® In the News Amgen (AMGN) entered into an agreement with …

AstraZeneca and Vertex Both Have Good News

August 21, 2019 0

AstraZeneca: Farxiga for Heart Failure with Reduced Ejection Fraction AstraZeneca (AZN) has good news. Many of them …

Moderna’s Investigational Zika Vaccine Is Granted FDA Fast Track Designation

August 20, 2019 0

From Moderna From the press release we learned that the U.S. Food and Drug Administration (FDA) …

The Bizarre Market

August 20, 2019 0

The Week in Review #41 We Are Still Witnessing … The bizarre market performance that started …

Why Akari Therapeutics Stock Price Rallied Today

August 14, 2019 0

Akari Therapeutics Stock Rallied Autoimmune and inflammatory disease treatments are works in progress with some approved …

Regeneron: Successful Cure for Ebola-Infected People. Read Also: The Midday Outperforming Biotech Stocks

August 13, 2019 0

Regeneron Product REGN-EB3 Saving Lives Regeneron (REGN) announced that an independent monitoring board ended its investigational product …

A Press Release About Regeneron Product REGN-EB3 Showing Superiority in Preventing Ebola Deaths

August 13, 2019 0

Palm Ebola Clinical Trial Stopped Early as Regeneron Product REGN-EB3 Therapy Shows Superiority to ZMapp in …

The Value of the Biotech Companies

August 12, 2019 0

Prohost Letter #434 Special Issue The Value of the Biotech Companies With a strong economy and …

Why Amgen’s Stock Is Up Over $11 Today

August 9, 2019 0

Amgen’s Stock Is Up Amgen (AMGN) is speeding towards reaching its true, fair value. In the Q2 …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

The Value of the Biotech Companies Continued

At bluebird bio an Investigational Gene Therapy is Demonstrating Promising Results

Atara Allogeneic Product ATA188 Will Confirm Whether EBV Infecting B Cells Could Cause a Difficult to Treat Kind of MS

Why Alder Biopharmaceuticals Stock Gained Over 83%. See Also: Prohost Picked Stocks Outperforming in a Down Market Day

Moderna Therapeutics: A Big Day Filled with Good News

About RegenxBio’s Agreement with Clearside Biomedical and More

Amgen’s Oncology Product AMG-510 Meeting An Unmet Need for Kras G12C Mutated Cancers

Vertex: In Pursuit of Cures

Outperforming Biotechs In a Bad Market Day

Gene Therapy and Other Treatments That Work at the Genetic Level

The Medicines Company Has Agreeable News

Amgen to Acquire Celgene’s Product Otezla at $13.4 Billion

AstraZeneca and Vertex Both Have Good News

Moderna’s Investigational Zika Vaccine Is Granted FDA Fast Track Designation

The Bizarre Market

Why Akari Therapeutics Stock Price Rallied Today

Regeneron: Successful Cure for Ebola-Infected People. Read Also: The Midday Outperforming Biotech Stocks

A Press Release About Regeneron Product REGN-EB3 Showing Superiority in Preventing Ebola Deaths

The Value of the Biotech Companies

Why Amgen’s Stock Is Up Over $11 Today